Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

AIM: The aim of this study is to determine the incidence of T790M mutations after progression on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) and median duration on TKI before progression on TKI. METHODS: Records of Rajiv Gandhi Cancer Institute and Research Centre, of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu Koyyala, Venkata Pradeep, Batra, Ullas, Jain, Parveen, Sharma, Mansi, Goyal, Pankaj, Medisetty, Pavani, Jajodia, Ankush, Maheshwari, Udip Dilip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120311/
https://www.ncbi.nlm.nih.gov/pubmed/30168457
http://dx.doi.org/10.4103/lungindia.lungindia_451_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120311/
https://www.ncbi.nlm.nih.gov/pubmed/30168457
http://dx.doi.org/10.4103/lungindia.lungindia_451_17

Ejemplares similares